Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Tenax Therapeutics Reports 7.05% ING Groep Stake (NASDAQ: TENX)

ING Groep N.V (OTC: INGVF). Holds a 7.05% beneficial ownership position in Tenax Therapeutics, Inc. (NASDAQ: TENX), equal to 2,639,666 common shares (2.64 million). The ownership statement identifies ING Capital Markets LLC as the entity holding the position and classifies the stake as passive.

Vinay Lochav | 01 September 2026

Frontier Group (NASDAQ: ULCC) Cuts Aircraft Lease Obligations by $260M

Frontier (NASDAQ: ULCC) Airlines, the wholly owned subsidiary, also expects the aircraft changes to maintain similar capacity with fewer aircraft.

Vinay Lochav | 01 September 2026

Idaho Copper (AMEX: COPR) Raises $18.0M Alongside NYSE American Uplisting

The company said theCapitalraise and listing change support its next phase of CuMo project development.

Vinay Lochav | 01 September 2026

MiniMed Group Sales Climb 16.6% to $843M (NASDAQ: MMED)

MiniMed Group’s first-quarter net sales rose 16.6% as reported and 15.8% organically to $843 million, with U.S. growth accelerating and international sales continuing to expand. The company raised fiscal 2027 organicRevenuegrowth guidance to approximately 10.5%, while maintaining adjusted EBITDAMarginguidance of approximately 16%.Key HighlightsMiniMed submitted …

Vinay Lochav | 01 September 2026

Tenax Therapeutics Reports 5.33% Sphera Stake (NASDAQ: TENX)

Sphera Funds Management Ltd. holds 1,993,496 shares of Tenax Therapeutics, Inc. (NASDAQ: TENX), representing 5.33% of its common stock. The position is reported on a passive basis, with the reporting parties certifying that the securities were not acquired or held to change or influence …

Vinay Lochav | 01 September 2026

Upstream Bio (NASDAQ: UPB) Plans Phase 3 Trials for 1,500 Patients

Verekitug Trials Set Broad Enrollment

Vinay Lochav | 01 September 2026

Crinetics (NASDAQ: CRNX) Investors Receive $85 Cash as Vertex Deal Takes Effect

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) completed its merger with Vertex Pharmaceuticals, converting each eligible share of common stock into the right to receive $85.00 in cash. Crinetics continued as the surviving corporation and became a wholly ownedSubsidiaryof Vertex. The transaction took effect on September …

Vinay Lochav | 01 September 2026

ISHARES TRUST Changes ETF (NYSE: SHV) Tickers, Names and Underlying Indexes

iSHARES TRUST (NYSE: SHV) approved the changes on August 6, 2026, and also approved corresponding changes for ISCB.

Vinay Lochav | 01 September 2026

Advisors' Inner Circle Fund II Adds Markus Hansen Effective September 1

Advisors' Inner Circle Fund II appoints Markus Hansen as a portfolio manager of the Vontobel International Equity Active ETF effective September 1, 2026. The supplement adds his name and position to the fund’s portfolio-manager information.

Vinay Lochav | 01 September 2026

Humana (NYSE: HUM) Reaffirms FY 2026 EPS Guidance at Least $6.52 GAAP

Humana Inc. (NYSE: HUM) intends to reaffirm FY 2026 guidance of at least $6.52 in diluted GAAP earnings per common share during meetings with investors and analysts. The company also intends to reaffirm adjusted EPS guidance of at least $9.00 for the year ending …

Vinay Lochav | 01 September 2026
Support

Hi! How can we help you today?

Loading…